Cited by 3,716Genetic Associations and EpidemiologyGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Open access
Maurano, Matthew T., Humbert, Richard, Rynes, Eric, Thurman, Robert E., Haugen, Eric, Wang, Hao, Reynolds, Alex P., Sandstrom, Richard +24 more·2012·Science

Abstract

Predictions of Genetic Disease: Many genome-wide association studies (GWAS) have identified loci and variants associated with disease, but the ability to predict disease on the basis of these genetic variants remains small. Maurano et al. (p. 1190 ; see the Perspective by Schadt and Chang ; see the cover) characterize the location of GWAS variants in the genome with respect to their proximity to regulatory DNA [marked by deoxyribonuclease I (DNase I) hypersensitive sites] by tissue type, disease, and enrichments in physiologically relevant transcription factor binding sites and networks. They found many noncoding disease associations in regulatory DNA, indicating tissue and developmental-specific regulatory roles for many common genetic variants and thus enabling links to be made between gene regulation and adult-onset disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1222794

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The majority of schizophrenia-associated variants do not directly index coding changes affecting protein structure.

    “As the majority of schizophrenia-associated variants do not directly index coding changes affecting protein structure”

    From DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia (2021) · cites this paper as Maurano et al., 2012

    The Abstract reports that about 93% of disease- and trait-associated GWAS variants lie in noncoding sequence. The section on regulatory DNA also finds that most intronic GWAS SNPs within DHSs do not strongly tag coding SNPs. These findings support the general point, but the paper does not establish that a majority of schizophrenia-associated variants specifically lack links to protein-structure changes. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The majority of multiple sclerosis risk variants appear to localise to gene regulatory regions, rather than coding sequence, and specifically to enhancer elements active in stimulated immune cell subsets.

    “The second challenge is that the majority of MS risk variants appear to localise to gene regulatory regions, rather than coding sequence,55 and specifically to enhancer elements active in stimulated immune cell subsets.56”

    From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [55]

    The Abstract states that about 93% of disease- and trait-associated variants overall lie in noncoding sequence. The ‘De novo identification of pathogenic cell types’ section reports enrichment of MS-associated variants in regulatory DNA of particular immune cell types, but does not establish that a majority of MS risk variants lie in regulatory regions rather than coding sequence. The separate claim about enhancers in stimulated immune cells carries citation 56, not this citation. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • A major component of the heritability of nearly all common diseases partitions to regions with enhancer-like signatures, particularly in disease-relevant cell types.

    “It is now widely recognized that a major component of the heritability of nearly all common diseases partitions to these regions, and in particular to regions that have enhancer-like signatures in disease-relevant cell types65.”

    From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [65]

    The section “Disease- and trait-associated variants are concentrated in regulatory DNA” (page unavailable) reports enrichment of GWAS-associated variants in DNase I hypersensitive sites across many diseases and traits. “De novo identification of pathogenic cell types” reports enrichment in particular cell types for Crohn’s disease, multiple sclerosis, and a cardiac trait. The paper does not quantify the share of heritability partitioning to these regions, establish this for nearly all common diseases, or show that the enriched regions specifically have enhancer-like signatures. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The heritable component of common disease risk distributes largely to non-coding regions and appears particularly enriched in enhancers specific to disease-relevant cell types.

    “Although most causal genetic variants for Mendelian disorders fall in protein-coding regions, the heritable component of common disease risk distributes largely to non-coding regions, and appears to be particularly enriched in enhancers that are specific to disease-relevant cell types.”

    From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [65]

    The Abstract reports that about 93% of disease- and trait-associated GWAS variants lie in noncoding sequence. The Discussion and ‘De novo identification of pathogenic cell types’ section report enrichment in regulatory DNA active in disease-relevant cell types. The paper measures enrichment in DNase I hypersensitive sites, however, not specifically in enhancers, and does not quantify the heritable component of risk. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • GWAS-detected genetic variants associated with complex traits and diseases are typically non-coding, non-promoter associated and highly enriched in enhancers.

    “The importance of enhancer variation in human pathology has been further highlighted by genome-wide association studies (GWAS), since GWAS-detected genetic variants associated with complex traits and diseases are typically non-coding, non-promoter associated and highly enriched in enhancers [184, 208, 209].”

    From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [209]

    The introductory passage reports that about 93% of disease- and trait-associated variants are noncoding. The section ‘Disease- and trait-associated variants are concentrated in regulatory DNA’ reports enrichment in DNase I hypersensitive sites (DHSs), and ‘DHSs harboring GWAS variants control distant phenotype-relevant genes’ identifies some of those sites as enhancers. The paper does not establish that GWAS variants are typically non-promoter-associated or specifically highly enriched in enhancers, rather than in regulatory DNA more broadly; page numbers were not supplied in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 47 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [42]Aho AV Kernighan BW Weinberger PJ The AWK Programming Language Addison Wesley Reading, MA 1 1988

Cited by

Sorted by citations

Authors
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., Shafer, A., Neri, F., Lee, K., Kutyavin, T., Stehling-Sun, S., Johnson, A. K., Canfield, T. K., Giste, E., Diegel, M., Bates, D., Hansen, R. S., Neph, S., Sabo, P. J., Heimfeld, S., Raubitschek, A., Ziegler, S., Cotsapas, C., Sotoodehnia, N., Glass, I., Sunyaev, S. R., Kaul, R., & Stamatoyannopoulos, J. A.
Affiliations
  • University of Washington (US)
  • Chinese Academy of Sciences (CN)
  • Fred Hutch Cancer Center (US)
  • Benaroya Research Institute (US)
  • Yale University (US)
  • Brigham and Women's Hospital (US)
Corresponding author
  • Maurano, Matthew T.
  • Humbert, Richard
  • Rynes, Eric
  • Stamatoyannopoulos, John A.
Venue
Science
Published
2012-09-07
Volume
337
Issue
6099
Pages
1190-1195
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2078059415
Cited by
3,716
References
47
Citations by year
2026: 215 · 2025: 261 · 2024: 296 · 2023: 260 · 2022: 288 · 2021: 352 · 2020: 306 · 2019: 273 · 2018: 270 · 2017: 252 · 2016: 269 · 2015: 249 · 2014: 239 · 2013: 163 · 2012: 17
FWCI
126.66
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL088456)
  • National Institute of Mental Health (F31MH094073)
  • National Human Genome Research Institute (U54HG004592)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056465)
  • National Institute of Environmental Health Sciences (U01ES01156, U01ES017156)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD000836)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
non-coding variants, regulatory DNA, DNase I hypersensitive sites, common diseases, fetal development, prenatal exposure, transcription factor binding sites, regulatory networks, Crohn's disease, multiple sclerosis, electrocardiogram, disease-associated variants
MeSH terms
Alleles, Chromatin, Crohn Disease, Deoxyribonuclease I, Disease, DNA, Electrocardiography, Fetus, Humans, Multiple Sclerosis, Phenotype, Promoter Regions, Genetic, Regulatory Sequences, Nucleic Acid, Transcription Factors, Genetic Variation, Genome, Human, Polymorphism, Single Nucleotide, Fetal Development, Regulatory Elements, Transcriptional, Gene Regulatory Networks, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review